Increased neuronal hypoxic tolerance induced by repetitive chemical hypoxia

Abstract

To investigate the effects of time interval and cumulative dosage of repetitive mild cellular hypoxia on shape of neurodegeneration and neuroprotection in mice, population spike amplitude (PSA) was measured during hypoxia and posthypoxic recovery in hippocampal slices from untreated control and mice pretreatedin vivo with a single or repeatedly intraperitoneal injection of 3-nitropropionate (3-NP). Posthypoxic recovery of PSA was dose-dependent in single pretreated slices, with maximal recovery on pretreatment attained with 20 mg/kg 3-NP (82±32%,P<0.01). Upon 5 and 9 treatments with 20 mg/kg 3-NP (dosage interval 3 days), PSA recovered to 38±9) % with the difference being not significant vs control group and (72±45)% with the difference being significant (P<0.05 to control,P<0.05 to 5 treatments), respectively. In contrast, with 2 days time interval, recovery after 5 and 9 treatments was (30±25)% and (16±14)%, respectively (without significant difference from control). Continued neuroprotection was also observed upon increase of dosage interval to 4 and 5 days. It was suggested that repetitive chemical hypoxia is a model for neurodegenerative disease and continued neuroprotection depending on time interval between repetitive hypoxic episodes rather than cumulative dosage. At appropriate time intervals increased neuronal hypoxic tolerance could be induced with number of hypoxic episodes.

Keywords

hypoxia / electrophysiology / Huntington's disease / 3-nitropropionate

References

[1] La FontaineM A, GeddesJ W, BanksA, et al. . 3-nitropropionic acid induced in vivo protein oxidation in striatal and cortical synaptosomes: insights into Huntington's disease. Brain Res, 2000, 858356-356

[2] ChyiT, ChangC. Temporal evolution of 3-nitropropionic acid-induced neurodegeneration in the rat brain by T2-weighted, diffusion-weighted, and perfusion magnetic resonance imaging. Neuroscience, 1999, 921035-1035

[3] Gonszalez-ZuluetaM, FeldmanA B, KlesseeL J, et al. . Requirement for nitric oxide activation of p-21 (ras)/extracellular regulated kinase in neuronal ischemic preconditioning. Proc Natl Acad Sci USA, 2000, 97436-436

[4] RiepeM W, EsclaireF, KasischkeK, et al. . Increased hypoxic and ischemic tolerance by chemical inhibition of oxidative phosphorylation: “chemical preconditioning”. J Cereb Blood Flow Metab, 1997, 17257-257

[5] WiegandF, LiaoW, BuschC, et al. . Respiratory chain inhibition induces tolerance to focal cerebral ischemia. J Cereb Blood Flow Metab, 1999, 191229-1229

[6] HamiltonB F, GouldD H. Nature and distribution of brain lesions in rats intoxicated with 3-nitropropionic acid: a type of hypoxic (energy deficient) brain damage. Acta Neuropathol, 1987, 72286-286

[7] LudolphA C, SeeligM, LudolphA, et al. . 3-nitropropionic acid decreases cellular energy levels and causes neuronal degeneration in cortical explants. Neurodegeneration, 1992, 1155-155

[8] RiepeM, LudolphA, SeeligM, et al. . Protective effects of glutamate antagonists after inhibition of SDH are not caused by preservation of ATP levels. Neuroreport, 1994, 52130-2130

[9] RiepeM W, KasischikeK, GerickeC A, et al. . Increase of hypoxic tolerance in rat hippocampal slices following 3-nitropropionic acid is not mediated by endogenous nerve growth factor. Neurosci Lett, 1996, 2119-9

[10] BealM F, BrouilletE, JenkinsB G, et al. . Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid. J Neurosci, 1993, 134181-4181

[11] MoncayoJ, De-FreitasG R, BogousslavskyJ, et al. . Do transient ischemic attacks have a neuroprotective effect?. Neurology, 2000, 542089-2089

[12] BealM F, HymanB T, KoroshetzW. Do defects in mitochondrial energy metabolism underlie the pathology of neurodegenerative diseases?. TINS, 1993, 16125-125